应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
INTS Intensity Therapeutics, Inc.
盘后交易 07-10 16:18:18 EDT
0.3163
+0.0071
+2.30%
盘后
0.3162
-0.0001
-0.03%
16:06 EDT
最高
0.3268
最低
0.3040
成交量
486.77万
今开
0.3118
昨收
0.3092
日振幅
7.37%
总市值
793.07万
流通市值
577.33万
总股本
2,507万
成交额
153.87万
换手率
26.67%
流通股本
1,825万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Intensity Therapeutics, Inc.盘中异动 股价大涨5.05%
市场透视 · 07-07
Intensity Therapeutics, Inc.盘中异动 股价大涨5.05%
Intensity Therapeutics, Inc.盘中异动 股价大跌5.20%报0.356美元
市场透视 · 05-22
Intensity Therapeutics, Inc.盘中异动 股价大跌5.20%报0.356美元
Intensity Therapeutics, Inc.盘中异动 早盘快速下挫5.93%报0.390美元
市场透视 · 05-21
Intensity Therapeutics, Inc.盘中异动 早盘快速下挫5.93%报0.390美元
Intensity Therapeutics, Inc.2025财年第一财季实现净利润-3.35百万美元,同比增加27.17%
市场透视 · 05-19
Intensity Therapeutics, Inc.2025财年第一财季实现净利润-3.35百万美元,同比增加27.17%
Intensity Therapeutics, Inc.盘中异动 早盘股价大跌5.31%报0.398美元
市场透视 · 05-19
Intensity Therapeutics, Inc.盘中异动 早盘股价大跌5.31%报0.398美元
Intensity Therapeutics, Inc.盘中异动 股价大跌5.32%报0.473美元
市场透视 · 05-16
Intensity Therapeutics, Inc.盘中异动 股价大跌5.32%报0.473美元
Intensity Therapeutics, Inc.盘中异动 急速上涨5.80%
市场透视 · 05-15
Intensity Therapeutics, Inc.盘中异动 急速上涨5.80%
Intensity Therapeutics, Inc.盘中异动 快速下跌5.08%
市场透视 · 05-14
Intensity Therapeutics, Inc.盘中异动 快速下跌5.08%
Intensity Therapeutics, Inc.盘中异动 股价大跌6.67%报0.530美元
市场透视 · 05-09
Intensity Therapeutics, Inc.盘中异动 股价大跌6.67%报0.530美元
Intensity Therapeutics, Inc.盘中异动 早盘股价大涨5.06%
市场透视 · 05-02
Intensity Therapeutics, Inc.盘中异动 早盘股价大涨5.06%
Intensity Therapeutics, Inc.盘中异动 股价大跌6.51%
市场透视 · 05-01
Intensity Therapeutics, Inc.盘中异动 股价大跌6.51%
Intensity Therapeutics, Inc.盘中异动 早盘股价大跌5.79%报0.600美元
市场透视 · 04-29
Intensity Therapeutics, Inc.盘中异动 早盘股价大跌5.79%报0.600美元
Intensity Therapeutics, Inc.盘中异动 早盘股价大跌34.34%
市场透视 · 04-25
Intensity Therapeutics, Inc.盘中异动 早盘股价大跌34.34%
Intensity Therapeutics, Inc.盘中异动 急速下跌7.69%
市场透视 · 04-24
Intensity Therapeutics, Inc.盘中异动 急速下跌7.69%
Intensity Therapeutics, Inc.盘中异动 大幅下跌5.67%
市场透视 · 04-22
Intensity Therapeutics, Inc.盘中异动 大幅下跌5.67%
Intensity Therapeutics, Inc.盘中异动 股价大涨5.35%报1.97美元
市场透视 · 04-15
Intensity Therapeutics, Inc.盘中异动 股价大涨5.35%报1.97美元
Intensity Therapeutics, Inc.盘中异动 股价大涨9.50%
市场透视 · 03-10
Intensity Therapeutics, Inc.盘中异动 股价大涨9.50%
Intensity Therapeutics, Inc.盘中异动 下午盘股价大涨7.24%报2.37美元
市场透视 · 03-05
Intensity Therapeutics, Inc.盘中异动 下午盘股价大涨7.24%报2.37美元
Intensity Therapeutics, Inc.盘中异动 早盘股价大跌6.41%报2.19美元
市场透视 · 03-03
Intensity Therapeutics, Inc.盘中异动 早盘股价大跌6.41%报2.19美元
Intensity Therapeutics, Inc.盘中异动 股价大涨8.68%报2.38美元
市场透视 · 02-25
Intensity Therapeutics, Inc.盘中异动 股价大涨8.68%报2.38美元
加载更多
公司概况
公司名称:
Intensity Therapeutics, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Intensity Therapeutics, Inc.于2012年11月30日在特拉华州注册成立。该公司是一家临床阶段的生物技术公司,开创了一种新的基于免疫的方法来治疗实体瘤癌症。该公司利用其DfuseRx技术平台创造专利药物配方,直接注射后迅速扩散到整个肿瘤,并将治疗剂扩散到癌细胞中。该公司的候选产品有可能诱导一种适应性免疫反应,不仅可以攻击注射的肿瘤,还可以攻击未注射的肿瘤。该公司的主要候选产品INT230-6正在开发中,用于治疗实体瘤患者,如肉瘤和乳腺癌患者。
发行价格:
--
{"stockData":{"symbol":"INTS","market":"US","secType":"STK","nameCN":"Intensity Therapeutics, Inc.","latestPrice":0.3163,"timestamp":1752177600000,"preClose":0.3092,"halted":0,"volume":4867693,"hourTrading":{"tag":"盘后","latestPrice":0.3162,"preClose":0.3163,"latestTime":"16:06 EDT","volume":656,"amount":207.4678064,"timestamp":1752177963823},"delay":0,"floatShares":18252587,"shares":25073200,"eps":-1.051783,"marketStatus":"盘后交易","change":0.0071,"latestTime":"07-10 16:18:18 EDT","open":0.3118,"high":0.3268,"low":0.304001,"amount":1538670.45576,"amplitude":0.073735,"askPrice":0.3185,"askSize":250,"bidPrice":0.3115,"bidSize":7700,"shortable":3,"etf":0,"ttmEps":-1.051783,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1752192000000},"marketStatusCode":4,"adr":0,"listingDate":1666324800000,"exchange":"NASDAQ","adjPreClose":0.3092,"preHourTrading":{"tag":"盘前","latestPrice":0.3092,"preClose":0.3092,"latestTime":"09:29 EDT","volume":364445,"amount":113357.63973435001,"timestamp":1752154196409},"postHourTrading":{"tag":"盘后","latestPrice":0.3162,"preClose":0.3163,"latestTime":"16:06 EDT","volume":656,"amount":207.4678064,"timestamp":1752177963823},"volumeRatio":1.136946},"requestUrl":"/m/hq/s/INTS","defaultTab":"news","newsList":[{"id":"2549530606","title":"Intensity Therapeutics, Inc.盘中异动 股价大涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2549530606","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549530606?lang=zh_cn&edition=full","pubTime":"2025-07-07 21:31","pubTimestamp":1751895065,"startTime":"0","endTime":"0","summary":"北京时间2025年07月07日21时31分,Intensity Therapeutics, Inc.股票出现异动,股价急速上涨5.05%。Intensity Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.09%。其相关个股中,Mustang Bio, Inc.、Artelo Biosciences, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大,Mustang Bio, Inc.、Artelo Biosciences, Inc.、Sonnet Biotherapeutics Holdings, Inc.较为活跃,换手率分别为1365.51%、744.45%、655.43%,振幅较大的相关个股有Nucana Plc、Azitra Inc、Annovis Bio, Inc.,振幅分别为9.70%、4.27%、4.24%。Intensity Therapeutics, Inc.公司简介:Intensity Therapeutics Inc 是一家处于临床阶段的生物技术公司,开创了一种新的基于免疫的治疗实体瘤癌症的方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707213106a43bf5dd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707213106a43bf5dd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INTS","BK4007","LENZ","BK4539","BK4139"],"gpt_icon":0},{"id":"2537894051","title":"Intensity Therapeutics, Inc.盘中异动 股价大跌5.20%报0.356美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537894051","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537894051?lang=zh_cn&edition=full","pubTime":"2025-05-22 22:34","pubTimestamp":1747924449,"startTime":"0","endTime":"0","summary":"北京时间2025年05月22日22时34分,Intensity Therapeutics, Inc.股票出现波动,股价急速下挫5.20%。Intensity Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.56%。其相关个股中,Vigil Neuroscience, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Liminatus Pharma Inc C/Wts 30/04/2030 涨幅较大,Polyrizon Ltd.、Biodexa Pharmaceuticals Plc、Nucana Plc较为活跃,换手率分别为2190.25%、2158.58%、681.74%,振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Imunon, Inc.、Celularity Inc C/Wts 16/07/2026 ,振幅分别为64.32%、55.11%、46.38%。Intensity Therapeutics, Inc.公司简介:Intensity Therapeutics Inc 是一家处于临床阶段的生物技术公司,开创了一种新的基于免疫的治疗实体瘤癌症的方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250522223409aa2c9708&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250522223409aa2c9708&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","INTS","BK4539","LENZ"],"gpt_icon":0},{"id":"2537936297","title":"Intensity Therapeutics, Inc.盘中异动 早盘快速下挫5.93%报0.390美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537936297","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537936297?lang=zh_cn&edition=full","pubTime":"2025-05-21 21:35","pubTimestamp":1747834557,"startTime":"0","endTime":"0","summary":"北京时间2025年05月21日21时35分,Intensity Therapeutics, Inc.股票出现波动,股价大幅跳水5.93%。Intensity Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.16%。其相关个股中,Psyence Biomedical Ltd C/Wts 25/01/2029、Protagenic Therapeutics Inc C/Wts 26/04/2026 、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025涨幅较大,Polyrizon Ltd.、Nucana Plc、Protagenic Therapeutics, Inc.较为活跃,换手率分别为6772.67%、476.71%、50.22%,振幅较大的相关个股有Revolution Medicines Inc C/Wts 17/12/2026 、Geovax Labs Inc C/Wts 29/09/2025、Relmada Therapeutics, Inc.,振幅分别为24.46%、20.41%、14.72%。Intensity Therapeutics, Inc.公司简介:Intensity Therapeutics Inc 是一家处于临床阶段的生物技术公司,开创了一种新的基于免疫的治疗实体瘤癌症的方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521213558a486e169&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521213558a486e169&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","BK4139","INTS","BK4539"],"gpt_icon":0},{"id":"2536366426","title":"Intensity Therapeutics, Inc.2025财年第一财季实现净利润-3.35百万美元,同比增加27.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536366426","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536366426?lang=zh_cn&edition=full","pubTime":"2025-05-20 00:00","pubTimestamp":1747670433,"startTime":"0","endTime":"0","summary":"5月20日,Intensity Therapeutics, Inc.公布财报,公告显示公司2025财年第一财季净利润为-3.35百万美元,同比增加27.17%;其中营业收入为0.00美元,每股基本收益为-0.22美元。从资产负债表来看,Intensity Therapeutics, Inc.总负债2.73百万美元,其中短期债务29000.00美元,资产负债比为1.13,流动比率为0.63。机构评级:截至2025年5月20日,当前有3家机构对Intensity Therapeutics, Inc.目标价做出预测,其中目标均价为6.50美元,其中最低目标价为1.50美元,最高目标价为14.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520000042a6e4efd7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520000042a6e4efd7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INTS","LENZ"],"gpt_icon":0},{"id":"2536423687","title":"Intensity Therapeutics, Inc.盘中异动 早盘股价大跌5.31%报0.398美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2536423687","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536423687?lang=zh_cn&edition=full","pubTime":"2025-05-19 21:39","pubTimestamp":1747661959,"startTime":"0","endTime":"0","summary":"北京时间2025年05月19日21时39分,Intensity Therapeutics, Inc.股票出现波动,股价快速跳水5.31%。Intensity Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.65%。其相关个股中,Protagenic Therapeutics Inc C/Wts 26/04/2026 、Protagenic Therapeutics, Inc.、Brainstorm Cell Therapeutics Inc.涨幅较大,Polyrizon Ltd.、Protagenic Therapeutics, Inc.、Nucana Plc较为活跃,换手率分别为7464.41%、4712.17%、2076.92%,振幅较大的相关个股有Protagenic Therapeutics Inc C/Wts 26/04/2026 、再鼎医药、Spero Therapeutics, Inc.,振幅分别为330.19%、106.69%、102.92%。Intensity Therapeutics, Inc.公司简介:Intensity Therapeutics Inc 是一家处于临床阶段的生物技术公司,开创了一种新的基于免疫的治疗实体瘤癌症的方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519213920a6e4d247&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519213920a6e4d247&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","INTS","BK4139","BK4539","LENZ"],"gpt_icon":0},{"id":"2536345480","title":"Intensity Therapeutics, Inc.盘中异动 股价大跌5.32%报0.473美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2536345480","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536345480?lang=zh_cn&edition=full","pubTime":"2025-05-17 00:58","pubTimestamp":1747414686,"startTime":"0","endTime":"0","summary":"北京时间2025年05月17日00时58分,Intensity Therapeutics, Inc.股票出现异动,股价急速下挫5.32%。截至发稿,该股报0.473美元/股,成交量10.6065万股,换手率0.69%,振幅4.16%。Intensity Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.30%。Intensity Therapeutics, Inc.公司简介:Intensity Therapeutics Inc 是一家处于临床阶段的生物技术公司,开创了一种新的基于免疫的治疗实体瘤癌症的方法。Intensity 的候选产品有潜力诱导一种适应性全身免疫反应,这种反应不仅能攻击被注射的肿瘤,还能攻击未被注射的肿瘤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250517005806975bf978&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250517005806975bf978&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","LENZ","BK4539","INTS"],"gpt_icon":0},{"id":"2535482063","title":"Intensity Therapeutics, Inc.盘中异动 急速上涨5.80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2535482063","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535482063?lang=zh_cn&edition=full","pubTime":"2025-05-15 23:05","pubTimestamp":1747321535,"startTime":"0","endTime":"0","summary":"北京时间2025年05月15日23时05分,Intensity Therapeutics, Inc.股票出现波动,股价快速上涨5.80%。Intensity Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.75%。Intensity Therapeutics, Inc.公司简介:Intensity Therapeutics Inc 是一家处于临床阶段的生物技术公司,开创了一种新的基于免疫的治疗实体瘤癌症的方法。Intensity 的候选产品有潜力诱导一种适应性全身免疫反应,这种反应不仅能攻击被注射的肿瘤,还能攻击未被注射的肿瘤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515230536a47fbc8c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515230536a47fbc8c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4007","INTS","LENZ","BK4139"],"gpt_icon":0},{"id":"2535073701","title":"Intensity Therapeutics, Inc.盘中异动 快速下跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2535073701","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535073701?lang=zh_cn&edition=full","pubTime":"2025-05-14 21:53","pubTimestamp":1747230836,"startTime":"0","endTime":"0","summary":"北京时间2025年05月14日21时53分,Intensity Therapeutics, Inc.股票出现异动,股价快速下挫5.08%。Intensity Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.36%。其相关个股中,Septerna, Inc.、蓝鸟生物、Rani Therapeutics Holdings, Inc.涨幅较大,Nucana Plc、Polyrizon Ltd.、Quoin Pharmaceuticals Ltd较为活跃,换手率分别为2691.29%、1894.80%、1367.75%,振幅较大的相关个股有Humacyte Inc C/Wts 27/08/2026 、Nucana Plc、Rani Therapeutics Holdings, Inc.,振幅分别为46.33%、31.31%、29.89%。Intensity Therapeutics, Inc.公司简介:Intensity Therapeutics Inc 是一家处于临床阶段的生物技术公司,开创了一种新的基于免疫的治疗实体瘤癌症的方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051421535697598a6a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051421535697598a6a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","INTS","LENZ","BK4539"],"gpt_icon":0},{"id":"2534436203","title":"Intensity Therapeutics, Inc.盘中异动 股价大跌6.67%报0.530美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2534436203","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534436203?lang=zh_cn&edition=full","pubTime":"2025-05-09 22:40","pubTimestamp":1746801608,"startTime":"0","endTime":"0","summary":"北京时间2025年05月09日22时40分,Intensity Therapeutics, Inc.股票出现波动,股价大幅下挫6.67%。截至发稿,该股报0.530美元/股,成交量3.0415万股,换手率0.20%,振幅3.15%。Intensity Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.04%。Intensity Therapeutics, Inc.公司简介:Intensity Therapeutics Inc 是一家处于临床阶段的生物技术公司,开创了一种新的基于免疫的治疗实体瘤癌症的方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509224008a4784be8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509224008a4784be8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","INTS","LENZ","BK4007","BK4139"],"gpt_icon":0},{"id":"2532784421","title":"Intensity Therapeutics, Inc.盘中异动 早盘股价大涨5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2532784421","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532784421?lang=zh_cn&edition=full","pubTime":"2025-05-02 21:31","pubTimestamp":1746192661,"startTime":"0","endTime":"0","summary":"北京时间2025年05月02日21时31分,Intensity Therapeutics, Inc.股票出现异动,股价大幅上涨5.06%。Intensity Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.23%。其相关个股中,Polyrizon Ltd.、Impact Biomedical, Inc.、Adaptive Biotechnologies Corporation涨幅较大,Pmgc Holdings Inc.、Polyrizon Ltd.、Adial Pharmaceuticals, Inc较为活跃,换手率分别为199.38%、140.68%、52.96%,振幅较大的相关个股有Polyrizon Ltd.、Adaptive Biotechnologies Corporation、Onconetix, Inc.,振幅分别为28.26%、10.46%、8.45%。Intensity Therapeutics, Inc.公司简介:Intensity Therapeutics Inc 是一家处于临床阶段的生物技术公司,开创了一种新的基于免疫的治疗实体瘤癌症的方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502213101aa2c81a8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502213101aa2c81a8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","BK4139","INTS"],"gpt_icon":0},{"id":"2532883180","title":"Intensity Therapeutics, Inc.盘中异动 股价大跌6.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2532883180","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532883180?lang=zh_cn&edition=full","pubTime":"2025-05-02 00:58","pubTimestamp":1746118693,"startTime":"0","endTime":"0","summary":"北京时间2025年05月02日00时58分,Intensity Therapeutics, Inc.股票出现异动,股价急速下挫6.51%。Intensity Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.62%。其相关个股中,Transcode Therapeutics, Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Seastar Medical Holding Corp C/Wts 28/10/2027 涨幅较大,Transcode Therapeutics, Inc.、Onconetix, Inc.、Processa Pharmaceuticals, Inc.较为活跃,换手率分别为417.16%、93.41%、56.48%,振幅较大的相关个股有Transcode Therapeutics, Inc.、Pasithea Therapeutics Corp C/Wts 12/08/2026 、Hookipa Pharma Inc.,振幅分别为77.82%、40.07%、40.00%。Intensity Therapeutics, Inc.公司简介:Intensity Therapeutics Inc 是一家处于临床阶段的生物技术公司,开创了一种新的基于免疫的治疗实体瘤癌症的方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502005813aa2c80f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502005813aa2c80f7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","INTS","BK4139","LENZ"],"gpt_icon":0},{"id":"2531875862","title":"Intensity Therapeutics, Inc.盘中异动 早盘股价大跌5.79%报0.600美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531875862","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531875862?lang=zh_cn&edition=full","pubTime":"2025-04-29 21:35","pubTimestamp":1745933731,"startTime":"0","endTime":"0","summary":"北京时间2025年04月29日21时35分,Intensity Therapeutics, Inc.股票出现波动,股价急速下跌5.79%。Intensity Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为1.82%。其相关个股中,Cyclacel Pharmaceuticals, Inc.、Lixte Biotechnology Holdings Inc C/Wts 30/11/2025 、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大,Zyversa Therapeutics, Inc.、Onconetix, Inc.、Galmed Pharmaceuticals Ltd.较为活跃,换手率分别为134.81%、49.17%、13.79%,振幅较大的相关个股有Cyclacel Pharmaceuticals, Inc.、Rein Therapeutics, Inc.、Zyversa Therapeutics, Inc.,振幅分别为26.68%、16.90%、13.23%。Intensity Therapeutics, Inc.公司简介:Intensity Therapeutics Inc 是一家处于临床阶段的生物技术公司,开创了一种新的基于免疫的治疗实体瘤癌症的方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429213532a6cd6ab0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429213532a6cd6ab0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INTS","BK4007","LENZ","BK4139"],"gpt_icon":0},{"id":"2530006139","title":"Intensity Therapeutics, Inc.盘中异动 早盘股价大跌34.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530006139","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530006139?lang=zh_cn&edition=full","pubTime":"2025-04-25 21:31","pubTimestamp":1745587916,"startTime":"0","endTime":"0","summary":"北京时间2025年04月25日21时31分,Intensity Therapeutics, Inc.股票出现异动,股价急速下跌34.34%。Intensity Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.32%。其相关个股中,Azitra Inc、Geovax Labs, Inc.、Lixte Biotechnology Holdings, Inc.涨幅较大,Azitra Inc、Briacell Therapeutics Corp.、Acrivon Therapeutics, Inc.较为活跃,换手率分别为186.24%、41.35%、40.45%,振幅较大的相关个股有Azitra Inc、Polyrizon Ltd.、Acrivon Therapeutics, Inc.,振幅分别为13.07%、8.57%、8.22%。Intensity Therapeutics, Inc.公司简介:Intensity Therapeutics Inc 是一家处于临床阶段的生物技术公司,开创了一种新的基于免疫的治疗实体瘤癌症的方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425213156a6c81d1e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425213156a6c81d1e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","BK4139","INTS"],"gpt_icon":0},{"id":"2529093680","title":"Intensity Therapeutics, Inc.盘中异动 急速下跌7.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529093680","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529093680?lang=zh_cn&edition=full","pubTime":"2025-04-24 21:35","pubTimestamp":1745501724,"startTime":"0","endTime":"0","summary":"北京时间2025年04月24日21时35分,Intensity Therapeutics, Inc.股票出现波动,股价大幅下挫7.69%。Intensity Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.10%。其相关个股中,Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Briacell Therapeutics Corp.、Cero Therapeutics Holdings, Inc.涨幅较大,Pmgc Holdings Inc.、Briacell Therapeutics Corp.、Mustang Bio, Inc.较为活跃,换手率分别为596.72%、583.19%、580.14%,振幅较大的相关个股有Cero Therapeutics Holdings, Inc.、Briacell Therapeutics Corp C/Wts 26/02/2026、Briacell Therapeutics Corp.,振幅分别为42.53%、33.36%、24.13%。Intensity Therapeutics, Inc.公司简介:Intensity Therapeutics Inc 是一家处于临床阶段的生物技术公司,开创了一种新的基于免疫的治疗实体瘤癌症的方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042421352494e11971&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042421352494e11971&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","LENZ","INTS"],"gpt_icon":0},{"id":"2529586129","title":"Intensity Therapeutics, Inc.盘中异动 大幅下跌5.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529586129","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529586129?lang=zh_cn&edition=full","pubTime":"2025-04-22 21:31","pubTimestamp":1745328693,"startTime":"0","endTime":"0","summary":"北京时间2025年04月22日21时31分,Intensity Therapeutics, Inc.股票出现波动,股价急速下挫5.67%。Intensity Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.01%。其相关个股中,阿诺医药、Ibio, Inc.、亚盛医药涨幅较大,Ocean Biomedical, Inc.、Lipella Pharmaceuticals Inc.、Ibio, Inc.较为活跃,换手率分别为158.76%、94.68%、34.20%,振幅较大的相关个股有Vincerx Pharma, Inc.、Revelation Biosciences, Inc.、Xbiotech Inc.,振幅分别为16.80%、9.55%、7.24%。Intensity Therapeutics, Inc.公司简介:Intensity Therapeutics Inc 是一家处于临床阶段的生物技术公司,开创了一种新的基于免疫的治疗实体瘤癌症的方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422213133a6c3da38&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422213133a6c3da38&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INTS","BK4007","LENZ","BK4139"],"gpt_icon":0},{"id":"2527426665","title":"Intensity Therapeutics, Inc.盘中异动 股价大涨5.35%报1.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527426665","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527426665?lang=zh_cn&edition=full","pubTime":"2025-04-16 01:59","pubTimestamp":1744739948,"startTime":"0","endTime":"0","summary":"北京时间2025年04月16日01时59分,Intensity Therapeutics, Inc.股票出现异动,股价大幅上涨5.35%。Intensity Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.52%。其相关个股中,Mural Oncology Plc、Protagenic Therapeutics Inc C/Wts 26/04/2026 、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 涨幅较大,Mural Oncology Plc、Dogwood Therapeutics, Inc.、Metavia Inc.较为活跃,换手率分别为1424.58%、976.10%、261.92%,振幅较大的相关个股有Skye Bioscience, Inc.、Mural Oncology Plc、Dogwood Therapeutics, Inc.,振幅分别为171.53%、97.08%、91.33%。Intensity Therapeutics, Inc.公司简介:Intensity Therapeutics Inc 是一家处于临床阶段的生物技术公司,开创了一种新的基于免疫的治疗实体瘤癌症的方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504160159099738da35&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504160159099738da35&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","LENZ","INTS"],"gpt_icon":0},{"id":"2518275867","title":"Intensity Therapeutics, Inc.盘中异动 股价大涨9.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518275867","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518275867?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:25","pubTimestamp":1741616707,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时25分,Intensity Therapeutics, Inc.股票出现波动,股价急速拉升9.50%。Intensity Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.44%。Intensity Therapeutics, Inc.公司简介:Intensity Therapeutics Inc 是一家临床阶段的生物技术公司,开创了一种新的基于免疫的方法来治疗实体瘤癌症。Intensity 的候选产品有可能诱导适应性全身免疫反应,不仅攻击注射的肿瘤,还攻击非注射的肿瘤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310222507a26a395a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310222507a26a395a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INTS","BK4139","LENZ"],"gpt_icon":0},{"id":"2517288129","title":"Intensity Therapeutics, Inc.盘中异动 下午盘股价大涨7.24%报2.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517288129","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517288129?lang=zh_cn&edition=full","pubTime":"2025-03-06 02:25","pubTimestamp":1741199118,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日02时25分,Intensity Therapeutics, Inc.股票出现波动,股价快速拉升7.24%。Intensity Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.34%。Intensity Therapeutics, Inc.公司简介:Intensity Therapeutics Inc 是一家临床阶段的生物技术公司,开创了一种新的基于免疫的方法来治疗实体瘤癌症。Intensity 的候选产品有可能诱导适应性全身免疫反应,不仅攻击注射的肿瘤,还攻击非注射的肿瘤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306022518a26107d4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306022518a26107d4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INTS","LENZ","BK4139"],"gpt_icon":0},{"id":"2516630537","title":"Intensity Therapeutics, Inc.盘中异动 早盘股价大跌6.41%报2.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516630537","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516630537?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:51","pubTimestamp":1741013463,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时51分,Intensity Therapeutics, Inc.股票出现异动,股价快速下挫6.41%。Intensity Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.02%。Intensity Therapeutics, Inc.公司简介:Intensity Therapeutics Inc 是一家临床阶段的生物技术公司,开创了一种新的基于免疫的方法来治疗实体瘤癌症。Intensity 的候选产品有可能诱导适应性全身免疫反应,不仅攻击注射的肿瘤,还攻击非注射的肿瘤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303225103abe639c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303225103abe639c3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","INTS","BK4139"],"gpt_icon":0},{"id":"2514090924","title":"Intensity Therapeutics, Inc.盘中异动 股价大涨8.68%报2.38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514090924","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514090924?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:33","pubTimestamp":1740494019,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时33分,Intensity Therapeutics, Inc.股票出现异动,股价大幅上涨8.68%。Intensity Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.21%。其相关个股中,Moleculin Biotech, Inc.、Adial Pharmaceuticals, Inc、Silexion Therapeutics Corp涨幅较大,Gt Biopharma, Inc.、Moleculin Biotech, Inc.、Adial Pharmaceuticals, Inc较为活跃,换手率分别为760.40%、469.26%、243.33%,振幅较大的相关个股有Adial Pharmaceuticals, Inc、Silexion Therapeutics Corp、Dominari Holdings Inc.,振幅分别为20.51%、14.67%、11.73%。Intensity Therapeutics, Inc.公司简介:Intensity Therapeutics Inc 是一家临床阶段的生物技术公司,开创了一种新的基于免疫的方法来治疗实体瘤癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022522333998924d2e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022522333998924d2e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INTS","LENZ","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.intensitytherapeutics.com","stockEarnings":[{"period":"1week","weight":0.0307},{"period":"1month","weight":-0.3609},{"period":"3month","weight":-0.8406},{"period":"6month","weight":-0.856},{"period":"1year","weight":-0.9348},{"period":"ytd","weight":-0.8243}],"compareEarnings":[{"period":"1week","weight":0.0058},{"period":"1month","weight":0.0407},{"period":"3month","weight":0.1896},{"period":"6month","weight":0.0751},{"period":"1year","weight":0.1228},{"period":"ytd","weight":0.0648}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Intensity Therapeutics, Inc.于2012年11月30日在特拉华州注册成立。该公司是一家临床阶段的生物技术公司,开创了一种新的基于免疫的方法来治疗实体瘤癌症。该公司利用其DfuseRx技术平台创造专利药物配方,直接注射后迅速扩散到整个肿瘤,并将治疗剂扩散到癌细胞中。该公司的候选产品有可能诱导一种适应性免疫反应,不仅可以攻击注射的肿瘤,还可以攻击未注射的肿瘤。该公司的主要候选产品INT230-6正在开发中,用于治疗实体瘤患者,如肉瘤和乳腺癌患者。","exchange":"NASDAQ","name":"Intensity Therapeutics, Inc.","nameEN":"Intensity Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Intensity Therapeutics, Inc.(INTS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Intensity Therapeutics, Inc.(INTS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Intensity Therapeutics, Inc.,INTS,Intensity Therapeutics, Inc.股票,Intensity Therapeutics, Inc.股票老虎,Intensity Therapeutics, Inc.股票老虎国际,Intensity Therapeutics, Inc.行情,Intensity Therapeutics, Inc.股票行情,Intensity Therapeutics, Inc.股价,Intensity Therapeutics, Inc.股市,Intensity Therapeutics, Inc.股票价格,Intensity Therapeutics, Inc.股票交易,Intensity Therapeutics, Inc.股票购买,Intensity Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Intensity Therapeutics, Inc.(INTS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Intensity Therapeutics, Inc.(INTS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}